Commerce.com Implements Poison Pill to Thwart Rezolve AI's Hostile Bid, Drawing Accusations of Shareholder Dilution
Summary
Rezolve AI (RZLV) has strongly criticized Commerce.com's (CMRC) board for adopting a "poison pill" (stockholder rights plan), calling it a "desperate" attempt to dilute shareholders and entrench the current board. This defensive maneuver by Commerce.com directly follows Rezolve AI's unsolicited all-stock acquisition offer, which has been escalating since April 8th with multiple SEC filings and news releases. The poison pill is a significant escalation in the hostile takeover battle, designed to make an acquisition more difficult and expensive, potentially impacting the value for Commerce.com shareholders. Rezolve AI is assessing the legality and fiduciary duty compliance of the Rights Plan and plans another investor call tomorrow, with the upcoming May 14th director election for Commerce.com also being a critical event to watch.
At the time of this announcement, CMRC was trading at $2.52 on NASDAQ in the Technology sector, with a market capitalization of approximately $207.1M. The 52-week trading range was $2.41 to $5.59. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.